SOURCE: The Bedford Report

The Bedford Report

March 23, 2010 13:15 ET

Bedfordreport.com: Complimentary Analyst Research on Pharmaceuticals Such as Bristol-Myers Squibb Co. (NYSE: BMY), Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA), AstraZeneca plc (NYSE: AZN) and Pfizer, Inc. (NYSE: PFE)

Note to Editors: The Following Is an Investment Opinion Being Issued by The Bedford Report.

TORONTO--(Marketwire - March 23, 2010) - The Bedford Report is pleased to announce that its latest Market Update analyzing recent news and events on Bristol-Myers Squibb Co. (NYSE: BMY), Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA), AstraZeneca plc (NYSE: AZN) and Pfizer, Inc. (NYSE: PFE) has been released.

On Sunday, the US House of Representatives passed a historic healthcare reform bill that should give an additional 32 million Americans access to health insurance. In this issue of The Bedford Report, we focus on the Pharmaceuticals industry, which will see a greater volume of patients, but also changes in taxes. Some Pharmaceuticals are looking stronger than others, and we separate the bulls from the bears in today's newsletter. There is much more analysis regarding these companies and many more available at www.bedfordreport.com.

Our updated analyst reports on Bristol-Myers Squibb, Teva Pharmaceutical Industries, AstraZeneca and Pfizer include:

-- An unbiased view and rating of the company

-- Recent key developments

-- Solid analyst summary -- who's saying what and why?

-- In-depth industry analysis and outlook

-- Major upcoming events to watch out for

Take the few minutes to register with us at www.BedfordReport.com and get access to numerous company reports and industry newsletters and stay abreast of market highlights so you can make the best investment decisions at the right time. Like you, we realize that timing is everything and so we only put out updates and analysis when the markets are ripe for immediate action.

BedfordReport.com has not been compensated by any of the above mentioned companies. We act as an independent research portal and are aware that all investment entails inherent risks.

Please view the full disclaimer: http://www.BedfordReport.com/disclaimer.php

Contact Information